| Sunday, December 16 |
| 2:30 - 5:30 p.m |
|
Registration |
| |
|
|
| 5:45 – 6:55 p.m |
|
Welcome Reception |
| |
|
|
Evening Session
7:00 p.m. |
|
|
Introduction
Robert Langer and Yasuhiko Tabata
Discussion Leader: Rodney Pearlman |
| |
|
|
| 8:30-9:00 p.m. |
Coffee Break |
|
| |
|
|
Juichi Ito
Professor, Kyoto University
A strategy for treatment of inner ear diseases using new drug delivery system |
| |
|
|
John Santini
President & Chief Executive Officer, MicroCHIPS, Inc.
Programmable drug delivery from implantable multi-reservoir devices |
| |
Paul Burke
Executive Director, Pharmaceutics & Drug Delivery, Amgen
Delivery enhanced biopharmaceuticals: Overcoming barriers to commercialization |
| |
Bob Miller
Vice President Polymer Chemistry, Genzyme Drug & Biomaterial R & D
Properties of Chemically Modified Hyaluronan and Other Macromolecules |
| |
| Monday, December 17 |
| |
| Morning Session |
| 7:00 - 8:00 a.m. |
|
Registration |
| |
|
|
| 8:30 a.m. |
|
|
| Discussion Leader: |
Nicholas Peppas |
|
| |
|
|
| 10:45-11:15 a.m. |
Coffee Break |
|
| |
|
|
Hideyuki Okano
Professor, Keio University School of Medicine
Novel therapeutic strategies for CNS-repair |
| |
|
|
Henry Brem
Professor, Johns Hopkins School of Medicine
Advances in brain tumor therapy |
| |
|
|
Mari Dezawa
Associate Professor, Kyoto University
Bone marrow stromal cells for auto-cell transplantation therapy: Applications for neuro- and muscle-degenerative diseases |
| |
|
|
Colin R. Gardner
Senior Vice President, Research & Site Head, TransForm Pharmaceuticals, Inc. (a J&J company)
Materials science impact on formulation design and performance |
| |
|
|
Larry Sternson
Chief Executive Officer, Avidimer Therapeutics
Dendrimers as nanomolecular platforms for targeted therapeutics |
| |
| Afternoon: Unscheduled |
| |
| Evening Sessions |
| 7:30 p.m. |
|
|
| Discussion Leader: |
Masatoshi Chiba |
|
| |
|
|
| 8:50-9:10 p.m. |
Refreshment Break |
|
| |
John Patton
Founder & Chief Scientific Officer, Nektar Therapeutics
New pulmonary and pegylation advances |
| |
Mitsuru Hashida
Professor, Kyoto University |
Yuriko Higuchi
Researcher, Kyoto University |
| Development of ligand modified quantum dots for imaging |
| |
Jeffrey Carbeck
Chief Technology Officer, WMR Biomedical, Inc.
In vivo printing of biomaterials |
| |
| Tuesday, December 18 |
| |
| Morning Session |
| 8:30 a.m. |
|
|
| Discussion Leader: |
Yutaka Hirai |
|
| |
|
|
| 10:30-11:00 a.m. |
Coffee Break |
|
| |
Atushi Maeda
Senior Manager, Astellas Pharma, Inc.
Study on enzymatic cleavable polymer coated long-circulating liposome system |
| |
Gerald Bernstein
Vice President, Medical Affairs, Director, Generex Biotechnology Corp
Buccal delivery of drugs for diabetes |
| |
Yasuhiro Matsumura
Chief, Investigative Treatment Division, National Cancer Center Hospital East
Micelle carrier system in cancer chemotherapy |
| |
Jeremy Heidel
Vice President, Research and Development and Chief Scientific Officer, Calando Pharmaceuticals
Targeted siRNA-containing formulations for clinical, systemic application |
| |
Hideyoshi Harashima
Professor, Hokkaido University
In vivo siRNA delivery with MEND |
| |
| Afternoon: Unscheduled |
| |
| Evening Session #1 |
| 7:30 p.m – 9:30 p.m. |
|
Oral Presentation of Posters - Selected from Poster |
| Discussion Leader: |
Michael Sefton |
|
| |
|
|
| 8:30 p.m. |
Refreshment Break |
|
| |
| Wednesday, December 19 |
| |
| Morning Session |
| 8:30 a.m. |
|
|
| Discussion Leader: |
Tsuneji Nagai and Yasuhiko Tabata |
|
| 10:30-11:00 a.m. |
Coffee Break |
|
| |
|
|
Akihiko Sano
Senior Manager, Dainippon Sumitomo Pharma Co., Ltd.
Atelocollagen-mediated technology as an effective drug delivery system for nucleic drugs |
| |
Akihiko Sano
Senior Manager, Dainippon Sumitomo Pharma Co., Ltd.
Atelocollagen-mediated technology as an effective drug delivery system for nucleic drugs |
| |
Gary Cleary
President & Chief Technology Officer, Corium International, Inc.
Advances in transdermal drug delivery using microporation |
| |
Glenn Batchelder
Chief Executive Officer, BIND Biosciences, Inc.
Targeted nanoparticles for therapeutic applications |
| |
Howard Rosen
Vice President, Commercial Strategy, Gilead Sciences, Inc.
What’s new in cystic fibrosis therapy |
| |
Mitsuru Akashi
Professor, Osaka University
Self-organizing nano-biomaterials: Nano-particles and nano-films |
| |
|
|
| Afternoon: Unscheduled |
| |
|
|
Evening Session:
Special session honoring Joseph Robinson |
| 7:30 p.m. |
|
|
| Discussion Leader: |
Sung Wan Kim |
|
| |
|
|
| 8:50 p.m. |
Refreshment Break |
|
| |
|
|
Min Young Lee
Vice President, Sam Yang Corporation
Launch of Genexol-PM with bio-polymers increasing therapeutic index (tentative) |
| |
Francis Szoka
Professor of Biopharmaceutical Sciences, University of California, San Francisco
New molecules for lipid based drug delivery |
| |
John Siebert
Chairman & Chief Executive Officer, CyDex, Inc.
Unique Pharmaceutical solubilization examples; Unique product differentiation |
| |
| Thursday, December 20 |
| Morning Session |
|
|
| 8:30 a.m. |
|
|
| Discussion Leader: |
Bruce Zetter |
|
| |
|
|
| 10:30-11:00 a.m. |
Coffee Break |
|
| |
|
|
Yasufumi Kaneda
Professor, Osaka University
Development of virosome-based drug delivery systems for cancer therapy |
| |
Thomas Schluep
Chief Scientific Officer, Insert Therapeutics, Inc.
Cyclodextrin polymer nanoparticles for cancer therapy: New molecules and first clinical results |
| |
Hikaru Sugihara
Ono Pharmaceutical Co., Ltd.
A new platform for gastric retentive system as a sustained release formulation |
| |
|
|
Joachim Kohn
Professor, Rutgers University
Combinatorial discovery approaches accelerate the development of drug eluting combination devices |
| |
|
|
| Afternoon: Unscheduled |
| |
|
|
| Evening Session |
|
|
| 7:30 p.m. |
|
Oral Presentation of Posters - Selected from Poster Session #2 |
| Discussion Leader |
Alexander Klibanov |
|
| |
|
|
| 8:30 p.m. |
Refreshment Break |
|
| |
|
|
AJOURN AT APPROXIMATELY 10:00 P.M.
THANK YOU FOR PARTICIPATING -
WE HOPE TO SEE YOU AGAIN AT
THE 10TH SYMPOSIUM IN 2009 |
